| 从“达菲”抗禽流感论医药技术创新价值 |
| |
| 引用本文： | 陈方和.从“达菲”抗禽流感论医药技术创新价值[J].药品评价,2013,0(10):6-8. |
| |
| 作者姓名： | 陈方和 |
| |
| 作者单位： | 陈方和 (厦门特宝生物工程股份有限公司,福建厦门361022)； |
| |
| 摘 要： | 达菲作为预防及治疗禽流感的药物,2009年销售额达到30亿美元的高峰。罗氏公司的科学家以莽草酸代替奎尼酸,改善了达菲最初的生产过程,解决了大规模生产的原料供应问题,而莽草酸原料主要从原产于中国的八角中提取。由于有严密的专利保护,罗氏公司可独享这块市场。由此说明技术创新对医药企业发展的重要性,提示中国经济取得重大发展后,应大力开展医药领域的创新,壮大自己的民族医药企业。
|
| 关 键 词： | 医药创新 达菲 八角 |
From Tamiflu Anti Avian Flu to Discuss the Value of Innovation in Pharmaceutical Enterprises |
| |
| CHEN Fang-he.From Tamiflu Anti Avian Flu to Discuss the Value of Innovation in Pharmaceutical Enterprises[J].Drug Evaluation,2013,0(10):6-8. |
| |
| Authors: | CHEN Fang-he |
| |
| Institution: | CHEN Fang-he Xiamen Amoytop Biotech.Co.Ltd,Xiamen 361022,China |
| |
| Abstract: | Tamiflu,as a medicine to prevent and treat H7N9 avian flu,achieved its sales peak of USD 3 billion in 2009.Roche scientists improved the original production process of Tamiflu by using shikimic acid to replace quinic acid and solved the raw material supply problem of large scale production.Shikimic acid is mainly extracted from aniseed originating in China.With the strict patent protection,Roche has exclusive privilege in relevant market.This case indicates the importance of technical innovation for the development of pharmaceutical enterprise.China should vigorously carry out the innovation in pharmaceutical field to boost the growth of national pharmaceutical enterprises. |
| |
| Keywords: | Pharmaceutical Innovation Tamiflu Aniseed |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
